# Trade Mark Journal No.2026/026 26 June 2026

## WO0000001910098 (5,44)

Office of origin: United States of America

Date of International Registration:4 February 2026
Date of designation in the UK: 4 February 2026

The mark consists of a sequence of right pointing arrows colored pink on the left shading into orange and the word "INGREZZA". The "ING" is colored pink on the left shading into orange and the "REZZA" is colored purple. The white in the mark is background and is not claimed as a feature.

The mark contains the colours pink, orange and purple.

The mark consists of a sequence of right pointing arrows colored pink on the left shading into orange and the word "INGREZZA". The "ING" is colored pink on the left shading into orange and the "REZZA" is colored purple. The white in the mark is background and is not claimed as a feature.

International priority date claimed: 26 August 2025 (United States of America) (99358616)

Class 5
  Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease.
Class 44
  Providing medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease.

Neurocrine Biosciences, Inc.

Representative: Mishcon De Reya LLP, Africa House, 70 Kingsway London WC2B 6AH UNITED KINGDOM